Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Electromedical & Electrotherapeutic Apparatus

Axogen, Inc. to acquire BioCircuit Technologies

Announced Sep 10, 2026 · Closed Oct 1, 2026 · Private target

Deal value$200M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash

Transaction

Acquirer
Axogen, Inc. (AXGN)
Target
BioCircuit Technologies
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Oct 1, 2026

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
BofA Securities
To the target
Piper Sandler

Classification

Sector
Healthcare
Buyer's industry
Electromedical & Electrotherapeutic Apparatus
Sources
  • 8-K (EX-99.1) · Sep 10, 2026
  • 8-K (EX-99.1) · Oct 1, 2026

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.